Glyceryl Trinitrate: History, Mystery, and Alcohol Intolerance

Glyceryl trinitrate (GTN) is one of the earliest known treatments for angina with a fascinating history that bridges three centuries. However, despite its central role in the nitric oxide (NO) story as a NO-donating compound, establishing the precise mechanism of how GTN exerts its medicinal benefit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Russell Pearson, Anthony Butler
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/16ad30072ab648eaa668366f55e2e575
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:16ad30072ab648eaa668366f55e2e575
record_format dspace
spelling oai:doaj.org-article:16ad30072ab648eaa668366f55e2e5752021-11-11T18:33:33ZGlyceryl Trinitrate: History, Mystery, and Alcohol Intolerance10.3390/molecules262165811420-3049https://doaj.org/article/16ad30072ab648eaa668366f55e2e5752021-10-01T00:00:00Zhttps://www.mdpi.com/1420-3049/26/21/6581https://doaj.org/toc/1420-3049Glyceryl trinitrate (GTN) is one of the earliest known treatments for angina with a fascinating history that bridges three centuries. However, despite its central role in the nitric oxide (NO) story as a NO-donating compound, establishing the precise mechanism of how GTN exerts its medicinal benefit has proven to be far more difficult. This review brings together the explosive and vasodilatory nature of this three-carbon molecule while providing an update on the likely in vivo pathways through which GTN, and the rest of the organic nitrate family, release NO, nitrite, or a combination of both, while also trying to explain nitrate tolerance. Over the last 20 years the alcohol detoxification enzyme, aldehyde dehydrogenase (ALDH), has undoubtedly emerged as the front runner to explaining GTN’s bioactivation. This is best illustrated by reduced GTN efficacy in subjects carrying the single point mutation (Glu504Lys) in ALDH, which is also responsible for alcohol intolerance, as characterized by flushing. While these findings are significant for anyone following the GTN story, they appear particularly relevant for healthcare professionals, and especially so, if administering GTN to patients as an emergency treatment. In short, although the GTN puzzle has not been fully solved, clinical study data continue to cement the importance of ALDH, as uncovered in 2002, as a key GTN activator.Russell PearsonAnthony ButlerMDPI AGarticleglyceryl trinitrateNO-donorsorganic nitratesnitric oxidealdehyde dehydrogenasenitrate toleranceOrganic chemistryQD241-441ENMolecules, Vol 26, Iss 6581, p 6581 (2021)
institution DOAJ
collection DOAJ
language EN
topic glyceryl trinitrate
NO-donors
organic nitrates
nitric oxide
aldehyde dehydrogenase
nitrate tolerance
Organic chemistry
QD241-441
spellingShingle glyceryl trinitrate
NO-donors
organic nitrates
nitric oxide
aldehyde dehydrogenase
nitrate tolerance
Organic chemistry
QD241-441
Russell Pearson
Anthony Butler
Glyceryl Trinitrate: History, Mystery, and Alcohol Intolerance
description Glyceryl trinitrate (GTN) is one of the earliest known treatments for angina with a fascinating history that bridges three centuries. However, despite its central role in the nitric oxide (NO) story as a NO-donating compound, establishing the precise mechanism of how GTN exerts its medicinal benefit has proven to be far more difficult. This review brings together the explosive and vasodilatory nature of this three-carbon molecule while providing an update on the likely in vivo pathways through which GTN, and the rest of the organic nitrate family, release NO, nitrite, or a combination of both, while also trying to explain nitrate tolerance. Over the last 20 years the alcohol detoxification enzyme, aldehyde dehydrogenase (ALDH), has undoubtedly emerged as the front runner to explaining GTN’s bioactivation. This is best illustrated by reduced GTN efficacy in subjects carrying the single point mutation (Glu504Lys) in ALDH, which is also responsible for alcohol intolerance, as characterized by flushing. While these findings are significant for anyone following the GTN story, they appear particularly relevant for healthcare professionals, and especially so, if administering GTN to patients as an emergency treatment. In short, although the GTN puzzle has not been fully solved, clinical study data continue to cement the importance of ALDH, as uncovered in 2002, as a key GTN activator.
format article
author Russell Pearson
Anthony Butler
author_facet Russell Pearson
Anthony Butler
author_sort Russell Pearson
title Glyceryl Trinitrate: History, Mystery, and Alcohol Intolerance
title_short Glyceryl Trinitrate: History, Mystery, and Alcohol Intolerance
title_full Glyceryl Trinitrate: History, Mystery, and Alcohol Intolerance
title_fullStr Glyceryl Trinitrate: History, Mystery, and Alcohol Intolerance
title_full_unstemmed Glyceryl Trinitrate: History, Mystery, and Alcohol Intolerance
title_sort glyceryl trinitrate: history, mystery, and alcohol intolerance
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/16ad30072ab648eaa668366f55e2e575
work_keys_str_mv AT russellpearson glyceryltrinitratehistorymysteryandalcoholintolerance
AT anthonybutler glyceryltrinitratehistorymysteryandalcoholintolerance
_version_ 1718431747955228672